Daniel R. Omstead
Daniel R. Omstead's purchase track record
Daniel R. Omstead has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/20/2023 | HQL | $277K | +5.7% | +12.5% | +18.7% |
| 9/20/2023 | HQH | $299K | +4.8% | +10.7% | +18.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
HQH Healthcare Fund Draws Attention for High Dividend Yield. Recent articles highlight HQH's dividend yield, which stands at 10.07% according to current data. One piece notes a cash yield above 9%, while another describes the fund as offering over 10% yield. These reports focus on the income potential of this healthcare-focused vehicle rather than recent operational changes.
Transaction History
| HQL | ▲ Buy | Open Market | 10,096 | $125K | 9/25/2023 | View on chart |
| HQH | ▲ Buy | Open Market | 9,500 | $149K | 9/25/2023 | View on chart |
| HQL | ▲ Buy | Open Market | 12,000 | $152K | 9/20/2023 | View on chart |
| HQH | ▲ Buy | Open Market | 9,500 | $151K | 9/20/2023 | View on chart |
| THW | ▼ Sell | Other | 6,442 | $92K | 4/6/2021 | View on chart |
| THQ | ▲ Buy | Open Market | 7,300 | $107K | 3/17/2020 | View on chart |
| THW | ▲ Buy | Open Market | 9,926 | $107K | 3/17/2020 | View on chart |
| THW | ▲ Buy | Open Market | 9,400 | $104K | 12/26/2018 | View on chart |
| THQ | ▲ Buy | Open Market | 6,000 | $105K | 10/25/2018 | View on chart |
| THQ | ▲ Buy | Open Market | 5,902 | $107K | 10/17/2018 | View on chart |
| THQ | ▲ Buy | Open Market | 5,500 | $97K | 10/11/2018 | View on chart |
| THQ | ▲ Buy | Open Market | 5,500 | $100K | 10/10/2018 | View on chart |
| THW | ▲ Buy | Open Market | 5,000 | $100K | 6/25/2015 | View on chart |
| THQ | ▲ Buy | Open Market | 1,000 | $20K | 7/28/2014 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
HQL Listed Among Top CEFs for September 2026 Yield
abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.
HQL Listed Among Top CEFs for September 2026 Yield. abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.